The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?

Accelerator™ Drug Development by Thermo Fisher Scientific​

 

       360°CDMO and CRO solutions

We accelerate your unique drug development journey with innovative 360° CDMO and CRO services to support your aspiration to get treatments to patients faster.

Developing novel therapies and delivering them to patients is high-risk. Adding multiple vendors to the mix increases complexity and delays timelines. As the industry’s only fully integrated CDMO and CRO, we provide seamless support at every step.

From drug substance to drug product development to clinical trial research, manufacturing, supply optimization, and logistics through to commercialization, we are committed to supporting your aspiration to get treatments to patients faster.

We combine proven end-to-end capabilities and state-of-the-art technologies with a dedicated team of global subject matter experts to simplify and streamline your drug development journey, getting you to the clinic—and to market—quicker. 

Our unique approach fosters collaboration and transparency across all phases, helping to drive speed, simplicity, and scalability.

Speed
Accelerating Innovation

Integrated timelines, joint project management, and streamlined information sharing

Simplicity
Simplifying the complex journey

Personalized planning and transparency across supply chains

Scalablility
Adapting to evolving needs

Global networks with regional expertise for scale-up across geographies

A quick Q&A with our commercial operations leader, Jennifer Cannon

Accelerator™ Drug Development, 360˚ CDMO and CRO solutions

With flexible and fully integrated CDMO and CRO capabilities, Thermo Fisher Scientific offers a comprehensive suite of world-class services and solutions across the drug development spectrum—from scientific discovery and assessing safety, efficacy, and outcomes, to managing clinical trial logistics and final drug product manufacturing.

  • Speed: Partnering with a single provider eliminates timeline gaps and regulatory challenges, proactively mitigating risks

  • Operational flexibility: Innovative solutions for various drug modalities tailored to meet your specific needs, locally and globally.

  • Collaborative partnership: Integrated expertise across all phases of drug development, providing a coordinated approach.

Helpful resources 

Our Quick to Care™ program is designed to streamline your drug substance and drug product development, demand planning, and clinical trial supply execution into a single, customized solution. We simplify your supply chain and accelerate drug development with a seamless, one-team approach. Unlike managing multiple vendors, this single-vendor solution offers advantages across the continuum, including:

  • Dedicated project management: An experienced program manager brings our integrated capabilities into a single solution for you, establishing and overseeing the governance process while leveraging technical experts from across our network. This single point of contact ensures coordination, communication, commitment, and accountability across the drug development supply chain.
  • Tailored solutions for your needs:Whether your goal is out-licensing at phase IIb or advancing your molecule to full commercialization, you need a trusted partner who understands your unique requirements. Our global team provides unified program management and scientific and technical insights, reducing redundancies and supporting success throughout the journey.

Helpful resources 

Now more than ever, you’re asked to do more in less time. Our Quick to Clinic™ program is a speed-focused solution tailored for small and large molecule drug development, as well as viral vector services. Quick to Clinic™ is designed to accelerate early development while using a proven process platform, ensuring that critical details are never overlooked.

  • Quick to Clinic™ for biologics: Move from transfection to IND in as little as 13 months with a carefully constructed program built on a proven process platform. This includes a high-yield, royalty-free expression system and supply assurance to mitigate raw material sourcing risks. Balancing speed and risk, Quick to Clinic™ prepares you for long-term commercial success. Learn more about our biologics services.
  • Quick to Clinic™ for small molecule OSD: With dedicated development hubs, engineered solutions, advanced chemistry, and innovative process technologies, we help you get it right the first time. This approach addresses molecular challenges from early development to commercialization, reducing experimental efforts and mitigating risk. Access an integrated drug program featuring flexible, tailored solutions and a range of early development programs that inject speed and adaptability into your small molecule’s lifecycle. Learn more about our small molecule OSD services.
  • Quick to Clinic™ for viral vector services: Quick to Clinic™ for viral vector services: An integrated development program using optimized, IND-ready platform processes for lentivirus and adeno-associated virus (AAV) manufacturing, scalable up to 200 L. Learn more about our viral vector services.

Helpful resources 

One shared commitment: Accelerate your drug development journey

How do we do it?

Integrate the solutions you need for successful drug development, clinical research, and clinical services

Solve technical challenges quickly by leveraging the expertise of scientists and technicians worldwide

Streamline development, manufacturing, research, and logistics through a global network of 60+ sites

Scale drug substance, drug product, clinical supply, and transportation management services

Launch and deliver new treatments to patients without time-consuming tech transfer delays

120+ biotech and pharma companies have partnered with Thermo Fisher Scientific across our CDMO and CRO services on 350+ protocols.


Benefits of partnering with us

With our breadth of experience, scientific expertise, and globally integrated network, we offer customizable solutions to shorten your drug development timeline and accelerate your path to market. We apply a science-driven, risk-based approach at every stage of development, manufacturing, and research, leveraging our global footprint and specialized scientific and therapeutic expertise to ensure your discovery reaches the patients who need it most.

We have one shared commitment: To accelerate your time to market.